Hostname: page-component-7c8c6479df-ph5wq Total loading time: 0 Render date: 2024-03-28T15:39:27.219Z Has data issue: false hasContentIssue false

P02-30 - Current Trends in Nonmedical Use of Prescription Extended-release Amphetamines and Methylphenidate

Published online by Cambridge University Press:  17 April 2020

A. Lindholm
Affiliation:
Shire Development, Inc., Wayne, USA
S. Varughese
Affiliation:
Shire Development, Inc., Wayne, USA
M.A. Sembower
Affiliation:
Pinney Associates, Inc., Pittsburgh, PA, USA
S. Shiffman
Affiliation:
Pinney Associates, Inc., Pittsburgh, PA, USA
S.H. Schnoll
Affiliation:
Pinney Associates, Inc., Bethesda, MD, USA
M.D. Ertischek
Affiliation:
Pinney Associates, Inc., Bethesda, MD, USA
E. St. Jean
Affiliation:
Pinney Associates, Inc., Bethesda, MD, USA
S. Rosen
Affiliation:
Shire Development, Inc., Wayne, USA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective

To examine rates of nonmedical use (NMU) of prescription extended-release (ER) amphetamines and ER methylphenidate, relative to availability.

Methods

Prescribing data were acquired from IMS Health. Data relevant to ER amphetamine and ER methylphenidate were collected from two studies in the RADARS® (Researched Abuse, Diversion and Addiction-Related Surveillance) System (Q3 2007-Q2 2009). First, the Drug Diversion System provides a law enforcement perspective based on surveys of diversion investigators throughout the US. Second, the Poison Center System provides data on exposures to prescription drugs based on spontaneous calls. RADARS System data are presented as rates per 1,000 Unique Recipients of Dispensed Drug (URDD) to account for drug availability.

Results

From July 2007-June 2009, 18,315,404 prescriptions were filled for ER amphetamines, 26,674,152 for ER methylphenidate. RADARS System Drug Diversion trends nearly overlap for ER amphetamine and ER methylphenidate, relative to URDD (running average of 0.042 vs. 0.024 drug diversion reports per 1,000 URDD). Similarly, trends in RADARS System Poison Center calls are generally similar for ER amphetamine and ER methylphenidate, although ER amphetamine trends slightly lower (running average of 0.15 vs. 0.22 intentional exposures per 1,000 URDD).

Conclusions

Trends from the US RADARS System, which controls for utilization rates, suggest diversion and poison center call rates are similar for ER amphetamine and ER methylphenidate.

Supported by funding from Shire Development Inc.

Type
Epidemiology
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.